Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Abiraterone Acetate × Genitourinary × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 194 Urinary Bladder Neoplasms 54 Carcinoma, Renal Cell 46 Kidney Neoplasms 33 Neoplasms 26 Non-Muscle Invasive Bladder Neoplasms 25 Carcinoma, Transitional Cell 16 Breast Neoplasms 14 Adenocarcinoma 12 Neoplasm Metastasis 10 Melanoma 9 Lung Neoplasms 9 Disease 7 Carcinoma, Non-Small-Cell Lung 7 Recurrence 6 Pancreatic Neoplasms 6 Endometrial Neoplasms 6 Colorectal Neoplasms 6 Testicular Neoplasms 5 Stomach Neoplasms 5 Head and Neck Neoplasms 5 Carcinoma, Hepatocellular 5 Urinary Incontinence 4 Sarcoma 4 Penile Neoplasms 4 Ovarian Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Wilms Tumor 3 Uterine Cervical Neoplasms 3 Urologic Neoplasms 3

Interventions

Prednisolone 1 BID protein, human 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting

Abiraterone Acetate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡